Preventive effect of flavangenol on ischemia/reperfusion-induced acute renal failure in rats

16Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

The effects of flavangenol on ischemia/reperfusion-induced acute renal failure (ARF) in rats were examined. Ischemic ARF was induced by occlusion of the left renal artery and vein for 45 min followed by reperfusion, 2 weeks after contralateral nephrectomy. Renal functional parameters such as blood urea nitrogen, plasma creatinine, creatinine clearance, urine flow, urinary osmolality and fractional excretion of sodium were measured. Renal function in ARF rats markedly decreased at 1 d after reperfusion. Pre-ischemic treatment with flavangenol (3-30 mg/kg, i.v.) attenuated the ischemia/reperfusion-induced renal dysfunction. Histopathological examination of the kidney of ARF rats revealed severe renal damage, such as tubular necrosis and proteinaceous casts in tubuli, which were also significantly suppressed by the administration of flavangenol. These findings suggest that flavangenol supplementation may be a promising candidate for treatments to improve the ischemia/reperfusioninduced renal injury. © 2005 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Ohkita, M., Nakajima, A., Ueda, K., Takaoka, M., Kiso, Y., & Matsumura, Y. (2005). Preventive effect of flavangenol on ischemia/reperfusion-induced acute renal failure in rats. Biological and Pharmaceutical Bulletin, 28(9), 1655–1657. https://doi.org/10.1248/bpb.28.1655

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free